- Why Toronto
- Startup Support
- Events & Training
- About Us
Get Social with Us
Igor Stagljar likens the process of commercializing his ground-breaking research into cell membrane proteins – which has yielded hundreds of new targets for drug-makers seeking cures for cancer and other deadly diseases – to building a highly automated Tesla factory.
Associate Professor James Carlyle was unconvinced at first. His doctoral student Oscar Aguilar had just brought him lab data showing how “natural killer” or NK cells, a key part of the immune system’s defence against pathogens and cancer, are targeted by a common virus.
A novel set of molecular models developed by U of T Scarborough researchers may help us better understand human biological systems, including the roots of various diseases.
University of Toronto researchers have identified a gene that determines whether the body will adapt to changing seasons.
Professor Kelly Metcalfe, of U of T’s Lawrence S. Bloomberg Faculty of Nursing, is leading the charge against hereditary breast and ovarian cancers by helping establish the standard protocol for addressing cancers associated with BRCA gene mutations.